Bioorganic and Medicinal Chemistry Letters p. 2569 - 2572 (1999)
Update date:2022-08-05
Topics:
Lowe III, John A.
Qian, Weimin
Volkmann, Robert A.
Heck, Steven
Nowakowski, Jolanta
Nelson, Robert
Nolan, Charles
Liston, Dane
Ward, Karen
Zorn, Stevin
Johnson, Celeste
Vanase, Michelle
Faraci, W. Stephen
Verdries, Kimberly A.
Baxter, James
Doran, Shawn
Sanders, Martin
Ashton, Mike
Whittle, Peter
Stefaniak, Mark
The synthesis and SAR of a series of 6-(4-(substituted)phenyl)-2-aminopyridines as inhibitors of nitric oxide synthase are described. Compound 3a from this series shows potent and selective inhibition of the human nNOS isoform, with pharmacokinetics sufficient to provide in vivo inhibition of nNOS activity.
View MoreXinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Shanghai Hanshare Industry Co.,Ltd.
Contact:86 21 20960688
Address:RM902-903,Building E, Wanda Plaza,No.26,Zhoukang Road, Pudong District, Shanghai, China
Contact:86-310-8067016
Address:East Fuhua Road,Tiexi Chemical Industrial Estate,Hebei,China
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Wuhan Fortuna Chemical Co.,Ltd
website:http://www.fortunachem.com
Contact:86-27-59207850
Address:Add: Room 2015, No.2 Building, Kaixin Mansion No.107 Jinqiao Avenue, Wuhan, China
Doi:10.1248/cpb.48.1558
(2000)Doi:10.1039/d0dt02931a
(2020)Doi:10.1021/jo035750g
(2004)Doi:10.1021/ic970765g
(1997)Doi:10.1007/s00706-020-02674-7
(2020)Doi:10.1039/c2dt32391e
(2013)